Cargando…

Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine

Detalles Bibliográficos
Autores principales:	Manzoni, Marco, Bosi, Alessandro, Fabris, Sonia, Lionetti, Marta, Salerio, Simone, Migliorini, Anna Chiara, Cavallaro, Francesca, Barbullushi, Kordelia, Rampi, Nicolò, Montefusco, Vittorio, Alessio, Maria Grazia, Neri, Antonino, Baldini, Luca, Sciumè, Mariarita, Tagliaferri, Elena, Fracchiolla, Nicola, Bolli, Niccolò
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358783/ https://www.ncbi.nlm.nih.gov/pubmed/35950209 http://dx.doi.org/10.1007/s44228-022-00002-w

Ejemplares similares

Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?
por: Barbullushi, Kordelia, et al.
Publicado: (2022)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia
por: Sciumè, Mariarita, et al.
Publicado: (2023)

Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
por: Manzoni, Martina, et al.
Publicado: (2020)

Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis
por: Ferla, Valeria, et al.
Publicado: (2020)

Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma
por: Manzoni, Martina, et al.
Publicado: (2020)

VEXAS syndrome
por: Grayson, Peter C., et al.
Publicado: (2021)

VEXAS-Syndrom
por: Zeeck, M., et al.
Publicado: (2022)

Thrombosis in VEXAS syndrome
por: Oo, Thet Mon, et al.
Publicado: (2021)

VEXAS Syndrome—Review
por: Zhang, Yue, et al.
Publicado: (2023)

An Unusual Coexistence of Primary Central Nervous System Non-Hodgkin's Lymphoma and Acute Promyelocytic Leukemia
por: Fracchiolla, Nicola Stefano, et al.
Publicado: (2018)

VEXAS syndrome with cutaneous nodules
por: Argobi, Yahya
Publicado: (2021)

VEXAS syndrome: a diagnostic puzzle
por: Ruffer, Nikolas, et al.
Publicado: (2023)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

Temozolomide-Induced Myelodysplasia
por: Natelson, Ethan A., et al.
Publicado: (2010)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
por: Huang, Huijun, et al.
Publicado: (2021)

VEXAS Syndrome: A Novelty in MDS Landscape
por: Templé, Marie, et al.
Publicado: (2022)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
por: Austestad, Janne, et al.
Publicado: (2023)

Intrapatient competition of VEXAS syndrome and CML clones
por: Djerbi, Nadia, et al.
Publicado: (2023)

Antineutrophil cytoplasmic antibodies in myelodysplasia.
por: Hull, D. R., et al.
Publicado: (1996)

Bone Marrow Immunity and Myelodysplasia
por: Lambert, Claude, et al.
Publicado: (2016)

Acquired spherocytosis in the setting of myelodysplasia
por: Karlsson, Linda Katharina, et al.
Publicado: (2022)

Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
por: Lionetti, Marta, et al.
Publicado: (2021)

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
por: Cattaneo, Daniele, et al.
Publicado: (2021)

Vexas: A new syndrome not always associated with hemopathy
por: Thomas, Benoît, et al.
Publicado: (2021)

Vasculitis associated with VEXAS syndrome: A literature review
por: Watanabe, Ryu, et al.
Publicado: (2022)

Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
por: Rabut, Audrey, et al.
Publicado: (2023)

Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
por: Sciumè, Mariarita, et al.
Publicado: (2021)

Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011)

New Insights on Iron Study in Myelodysplasia
por: El Husseiny, Noha M., et al.
Publicado: (2014)

Is Myelodysplasia a Consequence of Normal Aging?
por: Heibl, Sonja, et al.
Publicado: (2021)

Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome
por: Lacombe, Valentin, et al.
Publicado: (2022)

Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome
por: Vitale, Antonio, et al.
Publicado: (2022)

VEXAS syndrome: a newly discovered systemic rheumatic disorder
por: Kucharz, Eugenisz J.
Publicado: (2023)

Recurrent superior orbital fissure syndrome associated with VEXAS syndrome
por: Myint, Katie, et al.
Publicado: (2023)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
por: Motta, Irene, et al.
Publicado: (2021)

Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog
por: Natelson, Ethan A., et al.
Publicado: (2013)

Myelodysplasia is in the niche: novel concepts and emerging therapies
por: Bulycheva, E, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tisa8t6vcnhtcolaajd8euajgo